Why it’s difficult to declare the end of an Ebola outbreak

ebola
Image credit: UNMEER/Martine Perret

The World Health Organization on [July 24] declared the official end of the latest outbreak of Ebola in the Democratic Republic of the Congo, which tallied 54 cases, including 33 deaths. But a study published…in the Lancet Infectious Diseases highlights just how tenuous such declarations can be when it comes to Ebola.

The study, led by researchers at the Centers for Disease Control and Prevention, traced a puzzling cluster of Ebola cases in Liberia to a mother who appeared to have had a stealthy, undiagnosed infection for more than a year. The cluster came to light when the woman’s 15-year-old son arrived at a hospital in Monrovia on November 17, 2015—more than two months after the country had been declared free of the disease in the wake of a massive outbreak that began in 2013.

Such a scenario isn’t unheard of for Ebola. Earlier studies have found that the virus can lurk in men’s semen for up to 18 months after a victim recovers. It has also been spotted in the vaginal fluids and breast milk of asymptomatic women.

While researchers say such poorly understood, stealthy cases are rare, they still “highlight the risk of Ebola virus disease flare-ups even after an outbreak is declared over.” They urge continued vigilance and surveillance.

Read full, original post: Ebola mysteriously hid in a woman for more than a year before spreading

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Picture1-5
Science Disinformation Gap: The transatlantic battle over social media and censorship
ChatGPT Image May 10, 2026, 08_16_59 PM 2
Overmedicalization? RFK Jr.’s antidepressant crackdown raises conflict questions over his fee stake in Wisner Baum, the tort firm built on suing drug makers
Screenshot-2026-05-12-at-9.58.31-PM
'He seems fine': Marty Makary out as FDA commissioner
Picture1-1
Cooling the planet with balloons: Could a geoengineering gamble slow global warming?
ChatGPT-Image-May-12-2026-08_39_41-PM
GLP podcast: Big Pharma, Big Ag, Big Food—health harming industries or life-saving innovators?
Screenshot-2026-04-23-at-11.00.36-AM
Regulators' dilemma: Thalidomide, Metformin, and the cost of getting drug approvals wrong
Screenshot-2026-04-12-135256
Bixonimania: The fake disease scam that AI swallowed whole
Screenshot-2026-05-12-at-10.05.11-AM
Pro-vaccine “hero” vs. an anti-vax “villain”: ‘Bad Vaxx’ video stirs MAHA backlash
Picture1-14
When superbugs threaten vulnerable children: Can AI help solve antibiotic resistance?
Screenshot-2026-05-11-104424
Hantavirus outbreak research: Trump administration shut down study last year on rodent-to-human transmission
images
The never-ending GMO debate: Pros and cons
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.